MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDXG MiMedx Group, Inc.

盘前交易 05-18 04:50:24 EDT

3.56

+0.01

+0.28%

最高3.60	最低3.51	成交量122.12万
今开3.53	昨收3.55	日振幅2.68%
总市值5.30亿	流通市值3.87亿	总股本1.49亿
成交额433.87万	换手率1.12%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDXG","market":"US","secType":"STK","nameCN":"MiMedx Group, Inc.","latestPrice":3.56,"timestamp":1778875200000,"preClose":3.55,"halted":0,"volume":1221195,"delay":0,"changeRate":0.0028169014084507694,"floatShares":108772704,"shares":148945731,"eps":0.201026,"marketStatus":"盘前交易","change":0.01,"latestTime":"05-18 04:50:24 EDT","open":3.53,"high":3.6,"low":3.505,"amount":4338663.549912,"amplitude":0.026761,"askPrice":4.34,"askSize":100,"bidPrice":2.95,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.201026,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779111000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1366862400000,"exchange":"NASDAQ","adjPreClose":3.56,"postHourTrading":{"tag":"盘后","latestPrice":3.56,"preClose":3.56,"latestTime":"18:27 EDT","volume":7025,"amount":25008.94,"timestamp":1778884030247,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6997076480117917,"impliedVol":0.604,"impliedVolPercentile":0.3},"requestUrl":"/m/hq/s/MDXG/tweets","defaultTab":"tweets","newsList":[{"id":"1103525572","title":"TELA Bio董事会高层变动：主席道格·埃文斯及三名董事库尔特·阿扎巴津、文斯·伯吉斯、费德里卡·奥布莱恩将离任","url":"https://stock-news.laohu8.com/highlight/detail?id=1103525572","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103525572?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:45","pubTimestamp":1777581942,"startTime":"0","endTime":"0","summary":"医疗技术公司TELA Bio, Inc.宣布其董事会将迎来重大人事调整。公司现任董事会主席道格·埃文斯已决定辞去主席及董事职务。与此同时，库尔特·阿扎巴津、文斯·伯吉斯以及费德里卡·奥布莱恩三位董事也将一同离开董事会。\n此次多位核心董事的集中离任，标志着TELA Bio公司治理结构进入一个关键过渡期。公司未来的战略方向与领导层构成备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TELA","MDXG","ELUT","BK4198","BVS","BK4139","ANIK","AXGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110396189","title":"TELA Bio宣布董事会战略革新：引入四位资深商业领袖加速增长并推动盈利进程，同时公布2026年第一季度初步营收数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1110396189","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110396189?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:44","pubTimestamp":1777581859,"startTime":"0","endTime":"0","summary":"TELA Bio公司今日宣布对其董事会进行战略性革新，新引入四位拥有丰富行业经验的商业领袖。这一举措旨在加速公司业务增长，并推动实现盈利目标的战略路径。与此同时，该公司同步披露了2026年第一季度的初步营收业绩。此次董事会成员调整凸显了TELA Bio强化商业运营能力的决心。在公布董事会变动之际，TELA Bio还提前释放了2026年第一季度的营收信号。董事会焕新与营收数据公布的双重消息，标志着TELA Bio正积极推动企业发展的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXGN","BK4139","BK4082","BVS","ELUT","TELA","ANIK","BK4198","MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184558282","title":"MiMedx集团宣布重组与成本削减计划 首席运营官职位被裁撤","url":"https://stock-news.laohu8.com/highlight/detail?id=1184558282","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184558282?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:04","pubTimestamp":1776341072,"startTime":"0","endTime":"0","summary":"MiMedx Group, Inc.今日公布一系列成本削减措施，旨在优先关注增长机遇、优化运营流程并大幅降低运营开支。作为此次调整的一部分，公司已裁撤由Ricci Whitlow担任的首席运营官职位。公司首席执行官Joseph H. Capper表示：\"Ricci在MiMedx发展历程中作出不可磨灭的贡献，她以卓越的领导力助力公司运营体系的构建与扩张。Capper进一步指出：\"此次领导层变更是MiMedx全面重组与成本节约计划的一环。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614025851","title":"Mimedx Group, Inc盘中异动 快速下跌5.09%报5.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614025851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614025851?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:04","pubTimestamp":1772118267,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日23时04分，Mimedx Group, Inc股票出现波动，股价急速下跌5.09%。截至发稿，该股报5.01美元/股，成交量27.1975万股，换手率0.18%，振幅7.39%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.84%。Mimedx Group, Inc公司简介：MiMedx Group Inc 开发并销售由人类羊膜、出生组织以及人体皮肤和骨骼制成的再生生物材料产品和生物植入物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022623042895422373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022623042895422373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109681629","title":"MiMedx与Summit Products Group就多款创新外科与伤口护理产品达成独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1109681629","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109681629?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:27","pubTimestamp":1770218850,"startTime":"0","endTime":"0","summary":"MiMedx Group, Inc.  已正式与Summit Products Group签署独家分销协议，将负责后者多款创新外科及伤口护理产品的市场推广与销售工作。此次合作旨在整合双方在医疗领域的专业优势，共同拓展产品市场覆盖范围。这些产品融合了创新技术，旨在提升临床治疗效果并优化患者护理体验。双方将依托各自在研发、生产与渠道方面的资源优势，共同推动创新医疗产品的商业化进程，为医疗机构和患者提供更全面的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516454806","title":"Mimedx Group, Inc2024财年实现净利润42.00百万美元，同比减少37.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516454806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516454806?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931266,"startTime":"0","endTime":"0","summary":"3月3日，Mimedx Group, Inc公布财报，公告显示公司2024财年净利润为42.00百万美元，同比减少37.72%；其中营业收入为3.49亿美元，同比增加8.72%，每股基本收益为0.29美元。从资产负债表来看，Mimedx Group, Inc总负债70.81百万美元，其中短期债务2.31百万美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2025年3月3日，当前有5家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为13.40美元，其中最低目标价为12.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000136abe4acc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000136abe4acc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514380338","title":"坎托菲茨杰拉德公司：重申MiMedx Group(MDXG.US)评级，由增持调整至增持评级, 目标价由13.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380338","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380338?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674501,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申MiMedx Group(MDXG.US)评级，由增持调整至增持评级, 目标价由13.00美元调整至13.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28004148440840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176129083","title":"MiMedx Group第四季度每股收益$0.07，与预期一致，销售额$92.91百万，超预期$89.42百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1176129083","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176129083?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:12","pubTimestamp":1740604357,"startTime":"0","endTime":"0","summary":"MiMedx Group  公布季度每股收益$0.07，符合分析师共识预期。公司公布季度销售额$92.91百万，超出分析师共识预期的$89.42百万，超出3.90%。与去年同期销售额$86.83百万相比，增长了7.00%。以上内容来自Benzinga Earnings专栏，原文如下：MiMedx Group  reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 75 percent increase over earnings of $0.04 per share from the same period last year.  The company reported quarterly sales of $92.91 million which beat the analyst consensus estimate of $89.42 million by 3.90 percent.  This is a 7.00 percent inc","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MiMedx Group第四季度每股收益$0.07，与预期一致，销售额$92.91百万，超预期$89.42百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506510607","title":"Mimedx Group, Inc盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506510607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506510607?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:35","pubTimestamp":1738078518,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时35分，Mimedx Group, Inc股票出现波动，股价快速上涨5.11%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.04%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233518987572f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233518987572f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506930339","title":"Mimedx Group, Inc盘中异动 大幅下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506930339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506930339?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988378,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Mimedx Group, Inc股票出现异动，股价大幅下跌5.35%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为720.86%、41.82%、37.51%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc.，振幅分别为37.50%、14.59%、14.07%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232589874af6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232589874af6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490487660","title":"Mimedx Group, Inc盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490487660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490487660?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:21","pubTimestamp":1733847678,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时21分，Mimedx Group, Inc股票出现波动，股价快速拉升5.33%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.19%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211002118984b11b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211002118984b11b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484311084","title":"Mimedx Group, Inc盘中异动 早盘股价大跌5.95%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484311084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484311084?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:33","pubTimestamp":1732113209,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时33分，Mimedx Group, Inc股票出现异动，股价快速跳水5.95%。截至发稿，该股报8.69美元/股，成交量7.9288万股，换手率0.05%，振幅5.06%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.34%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483139804","title":"Mimedx Group, Inc盘中异动 股价大涨7.50%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483139804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483139804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:32","pubTimestamp":1731594754,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时32分，Mimedx Group, Inc股票出现波动，股价快速上涨7.50%。截至发稿，该股报8.03美元/股，成交量23.0549万股，换手率0.16%，振幅2.41%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为0.47%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB","MDXG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480983293","title":"Mimedx Group, Inc2024财年第三财季实现净利润7.88百万美元，同比减少7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480983293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480983293?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649656,"startTime":"0","endTime":"0","summary":"11月4日，Mimedx Group, Inc公布财报，公告显示公司2024财年第三财季净利润为7.88百万美元，同比减少7.62%；其中营业收入为84.06百万美元，同比增加2.88%，每股基本收益为0.06美元。从资产负债表来看，Mimedx Group, Inc总负债62.88百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2024年11月4日，当前有5家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.20美元，其中最低目标价为11.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479835038","title":"Mimedx Group, Inc盘中异动 早盘急速上涨17.40%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479835038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479835038?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:34","pubTimestamp":1730381643,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时34分，Mimedx Group, Inc股票出现波动，股价快速拉升17.40%。截至发稿，该股报6.68美元/股，成交量8.5479万股，换手率0.06%，振幅8.96%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.87%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mimedx.com","stockEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":-0.0825},{"period":"3month","weight":-0.3047},{"period":"6month","weight":-0.5176},{"period":"1year","weight":-0.4979},{"period":"ytd","weight":-0.4742}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiMedx Group, Inc.在佛罗里达州注册成立。该公司是专注于帮助人类愈合的胎盘生物制剂的先驱和领导者。凭借十多年来帮助临床医生管理慢性和难以愈合的伤口，MIMEDX致力于为应用于医疗保健的伤口护理、烧伤和手术领域提供领先的产品组合。该公司的愿景是通过不懈的创新，成为全球领先的康复解决方案提供商，以恢复生活质量。凭借深厚的专业知识、领先的同行评审数据以及胎盘生物制剂领域广泛的额外科学和真实世界证据库，MIMEDX开发和分销胎盘组织同种异体移植物，这些移植物使用受专利保护的专有工艺制造，适用于医疗保健的多个部门。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":0.001131},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.00649},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.071841},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.039235},{"month":5,"riseRate":0.714286,"avgChangeRate":0.1238},{"month":6,"riseRate":0.538462,"avgChangeRate":0.066117},{"month":7,"riseRate":0.384615,"avgChangeRate":0.011587},{"month":8,"riseRate":0.461538,"avgChangeRate":0.036935},{"month":9,"riseRate":0.230769,"avgChangeRate":-0.09977},{"month":10,"riseRate":0.692308,"avgChangeRate":0.062432},{"month":11,"riseRate":0.769231,"avgChangeRate":0.084769},{"month":12,"riseRate":0.615385,"avgChangeRate":0.027495}],"exchange":"NASDAQ","name":"MiMedx Group, Inc.","nameEN":"MiMedx Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiMedx Group, Inc.,MDXG,MiMedx Group, Inc.股票,MiMedx Group, Inc.股票老虎,MiMedx Group, Inc.股票老虎国际,MiMedx Group, Inc.行情,MiMedx Group, Inc.股票行情,MiMedx Group, Inc.股价,MiMedx Group, Inc.股市,MiMedx Group, Inc.股票价格,MiMedx Group, Inc.股票交易,MiMedx Group, Inc.股票购买,MiMedx Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}